Guangzhou South China Biological Medicine Co., Ltd.

Company Profile

Adhering to the development principle of technological innovation.

Industry Leadership and Strong Background

A majority-controlled subsidiary of Tianjin Ringpu Bio-Technology Co., Ltd. (Stock Code: 300119), a leading A-share listed company in China's veterinary sector, certified as a High-Tech Enterprise with a comprehensive corporate governance structure.

 

Outstanding R&D and Innovation Strength

Specializing in R&D, production, sales, and technical services of veterinary biological products, maintaining close strategic partnerships with authoritative institutions like South China Agricultural University, and hosting multiple provincial and national R&D platforms, including a "National Academician and Expert Enterprise Workstation."

 

Modern and Large-Scale Production Capacity

Operates three production lines that passed the Ministry of Agriculture and Rural Affairs' new GMP certification in China, including lines for avian influenza, embryo-cultured virus, and cell-cultured virus vaccines, with an annual capacity of 5 billion doses, making it one of the largest modern veterinary biological product manufacturing bases in South China.

 

Abundant Scientific Achievements and Honors

Undertaken over 40 national, provincial, and municipal projects, recognized with major honors such as the National Agriculture, Animal Husbandry, and Fishery Harvest Award First Prize and Guangdong Provincial Science and Technology Progress Award First Prize, and designated as a "Guangdong Provincial Famous Brand Product" and a "Guangdong Provincial Key Agricultural Leading Enterprise."

 

           

2004 Establishment

35 Having doctoral and master degrees

3 GMP production workshop

5.00Billion doses Annual production of various animal biological products

Development History

Adhering to the development principle of technological innovation.

2004

Guangzhou South China Biological Medicine Co., Ltd. was established

2005

Laboratory Animal Center, obtaining a license for the use of experimental animals

2006

Passed the GMP inspection of the Ministry of Agriculture.

2007

The first bottle of the H9 vaccine was launched in May.

2008

Key Agricultural Leading Enterprise in Guangdong Province

2012

Passed Ministry of Agriculture GMP re-inspection. Successfully passed high-tech enterprise review.

2013

Waterfowl Exclusive Avian Influenza Inactivated Vaccine (H5N2 Subtype, strain D7) launched.

2015

Forgered strategic partnership with Tianjin Ringpu Bio-Technology Co., Ltd. Became its majority-controlled subsidiary.

2017

Avian Influenza Virus H5 Subtype Inactivated Vaccine (strain D7 + strain rD8) launched.

2018

Passed Egypt GMP factory audit.

2019

First H5+H7 was launched: Reassorted Avian Influenza Virus (H5+H7) Trivalent Inactivated Vaccine (H5N2 strain rSD57 + strain rFJ56, H7N9 strain rGD76) launched.

2020

H5+H7 Upgrade: Reassorted Avian Influenza Virus (H5+H7) Trivalent Inactivated Vaccine (H5N2 strain rSD57 + strain rFJ56, H7N9 strain rLN79) launched.

2022

H5+H7 Upgrade: Reassorted Avian Influenza Virus (H5+H7) Trivalent Inactivated Vaccine (H5N2 strain rGD59+ rHN5801, H7N9 strain rHN7903) launched.

2025

H5 & H5+H7 Upgrade. Passed Belarus GMP factory audit.

Corporate Culture

Adhering to the development principle of technological innovation.

Corporate culture is the soft environment for a company's innovation mechanism: new drug research and development is a highly uncertain activity, a complex system engineering that requires the power of collective collaboration. The value of unity and cooperation makes unity and cooperation the basic code of conduct for the entire enterprise. Departments communicate and negotiate with each other, stimulate new ideas, solve new problems, improve the success rate of new drug research and development, and accelerate the launch of new drugs.

The fundamental way to attract high-quality talents is to respect and appreciate each other in work. The harmonious cooperation between leaders and subordinates, colleagues and colleagues, and the organic combination of strict systems and human affinity are the fundamental guarantees for the prosperity and progress of the company.

At the same time, through persistent promotional and educational activities, employees are strongly stimulated to strengthen the company's values; Highlight the dominant position of employees and create a good and harmonious internal environment for the enterprise.


Leadership Care

Adhering to the development principle of technological innovation.

We warmly welcome Shi Xia, Secretary of the Party Group and Director of the Science and Technology Innovation Bureau of Zengcheng Development Zone
We warmly welcome Dean Xie and General Manager Ke Lang Cai from Jiangxi Academy of Agricultural Sciences to our company for exchange